Introduction

InVivo Therapeutics announces first subject enrolled in pilot trial for chronic spinal cord injury

InVivo Therapeutics announces first subject enrolled in pilot trial for chronic spinal cord injury

The first subject has been enrolled in the pilot study of InVivo’s Neuro-Spinal Scaffold for the treatment of complete traumatic spinal cord injury (SCI) at the Barrow Neurological Institute in Phoenix, AZ. The objective of the pilot study is to evaluate the safety and feasibility of the Neuro-Spinal Scaffold as well as to gather preliminary evidence of effectiveness.

Read more…